Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

If you are a Jazz employee, please apply via the Internal Career site.

Jazz Pharmaceuticals is seeking a Clinical Development Lead for Solid Tumor Oncology focusing on BTC (Biliary Tract Cancer) and GEA (Gastroesophageal Adenocarcinoma). The selected candidate will play a crucial role in leading the late-stage development and life-cycle management of a key Oncology asset for BTC and GEA. Responsibilities include strategic leadership, clinical development planning, cross-functional collaboration, regulatory compliance, clinical trial oversight, data analysis, risk management, external collaboration, budget, resource management, and team development.

Requirements

• Demonstrable experience in leading Solid Tumor Oncology asset development successfully.
• Proven track record in leading high-performing clinical development teams.
• Executive presence to articulate complex insights to executive level audiences.
• MD required; Board certified Oncologist preferred.
• Higher postgraduate degree preferred.
• Clinical experience in solid tumor oncology, particularly BTC or Gastrointestinal cancers.

Jazz Pharmaceuticals is an equal opportunity employer.